Epithelial and stromal expression of syndecan-2 in pancreatic carcinoma

Anticancer Research

Volumn 30, Issue 7, 2010, Pages 2749-2753

  Hrabar, Davor ^a   Aralica, Gorana ^b,c   Gomerčić, Marija ^a   Ljubičić, Neven ^a,c   Krušlin, Božo ^a,c   Tomas, Davor ^a,c  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^b University of Zagreb School of Medicine   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Pancreatic carcinoma; Prognosis; Syndecan 2

Indexed keywords

SYNDECAN 2; TUMOR MARKER;

ACINAR CELL; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CLINICAL ASSESSMENT; CORRELATION ANALYSIS; EPITHELIUM CELL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STROMA CELL; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; EPITHELIAL CELLS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PROGNOSIS; STROMAL CELLS; SYNDECAN-2;

EID: 77955815599     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J and Zako M: Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68: 729-777, 1999. (Pubitemid 29449208)
2. Rapraeger AC: Syndecan-regulated receptor signaling. J Cell Biol 149: 995-998, 2000.
3. Morgan MR, Humphries MJ and Bass MD: Synergistic control of cell adhesion by integrins and syndecans. Nat Rev Mol Cell Biol 8: 957-969, 2007.
4. Kim CW, Goldberger OA, Gallo RL and Bernfield M: Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns. Mol Biol Cell 5: 797-805, 1994.
5. Loussouarn D, Campion L, Sagan C, Frenel JS, Dravet F, Classe JM, Pioud-Martigny R, Berton-Rigaud D, Bourbouloux E, Mosnier JF, Bataille FR and Campone M: Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomas. Br J Cancer 98: 1993-1998, 2008.
6. Choi DS, Kim JH, Ryu HS, Kim HC, Han JH, Lee JS and Min CK: Syndecan-1, a key regulator of cell viability in endometrial cancer. Int J Cancer 121: 741-750, 2007. (Pubitemid 47106202)
7. Wiksten JP, Lundin J, Nordling S, Lundin M, Kokkola A, von Boguslawski K and Haglund C: Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer. Int J Cancer 95: 1-6, 2001.
8. Hashimoto Y, Skacel M and Adams JC: Association of loss of epithelial syndecan-1 with stage and local metastasis of colorectal adenocarcinomas: an immunohistochemical study of clinically annotated tumors. BMC Cancer 8: 185, 2008. (Pubitemid 352025054)
9. Conejo JR, Kleeff J, Koliopanos A, Matsuda K, Zhu ZW, Goecke H, Bicheng N, Zimmermann A, Korc M, Friess H and Buchler MW: Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers. Int J Cancer 88: 12-20, 2000.
10. Juuti A, Nordling S, Lundin J, Louhimo J and Haglund C: Syndecan-1 expression - a novel prognostic marker in pancreatic cancer. Oncology 68: 97-106, 2005. (Pubitemid 41158964)
11. Kylanpaa L, Hagstrom J, Lepisto A, Linjama T, Karkkainen P, Kiviluoto T and Haglund C: Syndecan-1 and tenascin expression in cystic tumors of the pancreas. JOP 10: 378-382, 2009.
12. Marynen P, Zhang J, Cassiman JJ, Van den Berghe H and David G: Partial primary structure of the 48- and 90-kiloDalton core proteins of cell surface-associated heparan sulfate proteoglycans of lung fibroblasts. Prediction of an integral membrane domain and evidence for multiple distinct core proteins at the cell surface of human lung fibroblasts. J Biol Chem 264: 7017-7024, 1989. (Pubitemid 19114820)
13. Essner JJ, Chen E and Ekker SC: Syndecan-2. Int J Biochem Cell Biol 38: 152-156, 2006.
14. Tkachenko E, Rhodes JM and Simons M: Syndecans: new kids on the signaling block. Circ Res 96: 488-500, 2005. (Pubitemid 40463457)
15. Huang JW, Chen CL and Chuang NN: P120-GAP associated with syndecan-2 to function as an active switch signal for Src upon transformation with oncogenic ras. Biochem Biophys Res Commun 329: 855-862, 2005.
16. Park H, Kim Y, Lim Y, Han I and Oh S: Syndecan-2 mediates adhesion and proliferation of colon carcinoma cells. J Biol Chem 277: 29730-29736, 2002.
17. Kim Y, Park H, Lim Y, Han I, Kwon HJ, Woods A and Oh ES: Decreased syndecan-2 expression correlates with trichostatin-A- induced morphological changes and reduced tumorigenic activity in colon carcinoma cells. Oncogene 22: 826-830, 2003. (Pubitemid 36255817)
18. Han I, Park H and Oh ES: New insights into syndecan-2 expression and tumourigenic activity in colon carcinoma cells. J Mol Histol 35: 319-326, 2004. (Pubitemid 40585317)
19. Choi S, Kim Y, Park H, Han IO, Chung E, Lee SY, Kim YB, Lee JW, Oh ES and Yi JY: Syndecan-2 overexpression regulates adhesion and migration through cooperation with integrin alpha2. Biochem Biophys Res Commun 384: 231-235, 2009.
20. Huang X, Xiao DW, Xu LY, Zhong HJ, Liao LD, Xie ZF and Li EM: Prognostic significance of altered expression of SDC2 and CYR61 in esophageal squamous cell carcinoma. Oncol Rep 21: 1123-1139, 2009.
21. Contreras HR, Ledezma RA, Vergara J, Cifuentes F, Barra C, Cabello P, Gallegos I, Morales B, Huidobro C and Castellon EA: The expression of syndecan-1 and -2 is associated with Gleason score and epithelial mesenchymal transition markers, E-cadherin and beta-catenin, in prostate cancer. Urol Oncol 2009.
22. Popovic A, Demirovic A, Spajic B, Stimac G, Kruslin B and Tomas D: Expression and prognostic role of syndecan-2 in prostate cancer. Prostate Cancer Prostatic Dis 13: 78-82, 2010.
23. Sobin LH and Wittekind C (eds.). International Union Against Cancer (UICC): TNM Classification of Malignant Tumours, 5th ed. New York: Wiley Liss, 1997.
24. Boutin EL, Sanderson RD, Bernfield M and Cunha GR: Epithelial mesenchymal interactions in uterus and vagina alter the expression of the cell surface proteoglycan, syndecan. Dev Biol 148: 63-74, 1991. (Pubitemid 121004747)
25. Bai F, Guo X, Yang L, Wang J, Shi Y, Zhang F, Zhai H, Lu Y, Xie H, Wu K and Fan D: Establishment and characterization of a high metastatic potential in the peritoneum for human gastric cancer by orthotopic tumor cell implantation. Dig Dis Sci 52: 1571-1578, 2007.
26. Lee JH, Park H, Chung H, Choi S, Kim Y, Yoo H, Kim TY, Hann HJ, Seong I, Kim J, Kang KG, Han IO and Oh ES: Syndecan-2 regulates the migratory potential of melanoma cells. J Biol Chem 284: 167-175, 2009.